Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Remedy Meds claims to offer a prescription-based GLP-1 program designed to target hunger and fat storage at the source
Feeling the GLP-1 Gut Shift
The constipation pathway: Predominant GLP-1 receptor expression in the colon Slowed peristalsis exceeds the gut's ability to adapt Increased water absorption Hard, infrequent stools The diarrhea pathway: Predominant GLP-1 receptor expression in the small intestine Slowed small bowel transit allows bacterial overgrowth or malabsorption Osmotic load in the colon from unabsorbed nutrients Loose, frequent stools The mixed pathway (most common): Early diarrhea (weeks 1-4) from acute gastric retention and bile acid malabsorption Transition to constipation (weeks 4-12) as colonic adaptation lags behind gastric adaptation Resolution to normal or near-normal bowel habits after 12-16 weeks A 2024 paper in Gut (Acosta et al.) measured GLP-1 receptor density in colonic biopsies from 86 patients starting semaglutide
Ensuring adequate protein intake (71+ grams daily for lactating mothers), staying hydrated, and maintaining micronutrient stores through diet or supplementation supports both milk quality and maternal metabolic health
Maybe some new breakouts or uneven tone
Our program combines semaglutide or tirzepatide with DEXA tracking to ensure you're losing fatnot muscle
